Keeping Track: Mycovia Vivjoa, BMS Camzyos Approvals Bring FDA’s 2022 Novel Drug Tally To 12

 
• By Bridget Silverman
  
umbrella in the rain
There wasn't a deluge of NMEs of approved in April, but the last two to get through benefited from the umbrella of well-crafted safety labeling. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers